Civil Litigation,
Intellectual Property
Mar. 20, 2018
Biotech company sues one rival, seeks injunction against another
Biotechnology company Illumina Inc. has sued Natera Inc. for patent infringement over its use of a noninvasive prenatal test.
Biotechnology company Illumina Inc. sued Natera Inc. for patent infringement over its use of a noninvasive prenatal test.
The suit follows Illumina's $27 million win against Ariosa Diagnostics Inc. in January for infringement claims on other patents for prenatal tests. On Friday, Illumina also filed a motion for permanent injunction in that case -- the same day as the new complaint against Natera.
$95
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In